Sfakianaki Ourania, Tzardi Maria, Voumvouraki Argyro, Afgoustaki Aikaterini, Koulentaki Meri, Kouroumalis Elias
Ourania Sfakianaki, Argyro Voumvouraki, Elias Kouroumalis, Liver Research Laboratory, Medical School, University of Crete, 71003 Voutes, Crete, Greece.
World J Hepatol. 2013 Oct 27;5(10):568-76. doi: 10.4254/wjh.v5.i10.568.
To investigate the presence of autoantibodies directed against liver sinusoidal cells in primary biliary cirrhosis (PBC).
Liver biopsies from 21 PBC patients were studied and compared with 12 liver biopsies from disease controls [3 patients with hepatitis B (HBV) virus, 3 patients with hepatitis C virus (HCV), 3 patients with non-alcoholic steatohepatitis and 3 patients with acute alcoholic hepatitis (AAH)]. As healthy controls, we used tissue specimens adjacent to metastatic liver adenocarcinoma. Normal serum was taken from staff members of the unit. The determination of the cell type targeted by autoantibodies present in the patients sera was performed by indirect immunofluorescence (IIF) analysis using paraffin-embedded liver sections as a substrate. Sera from homologous or heterologous PBC patients or sera from the disease control group were used as primary antibodies. The presence of autoantibodies was identified using confocal microscopy.
In total, 18/21 (85.7%) PBC patients exhibited positive staining in the sinusoidal cells, 10/21 (47.6%) in lymphocytes, 8/21 (38%) in cholangiocytes and 7/21 (33.3%) in hepatocytes, when homologous serum and fluorescein isothiocyanate-conjugated immunoglobulin type G (IgG) secondary antibody were used. PBC sections incubated with heterologous PBC serum showed reduced staining (20% for sinusoidal cells, 20% for lymphocytes, 20% for cholangiocytes and 13.3% for hepatocytes). When IgM immunoglobulin, instead of IgG, was used as secondary antibody, positive staining was observed in 75% of lymphocytes, 62.5% of cholangiocytes, 37.5% of hepatocytes and 50% of the sinusoidal cells with a much stronger staining intensity. No staining was observed when either normal or PBC sera were used as a primary antibody on liver sections from the disease control group. When PBC sera were incubated with healthy control sections, weak positive staining of cholangiocytes was observed in 3/21 (14.3%) PBC serum samples. Steatohepatitis serum on PBC sections gave a positive staining of some hepatocytes and lymphocytes but no staining on viral hepatitis sections. Incubation with HBV sera stained some hepatocytes, cholangiocytes and intra-sinusoidal or portal lymphocytes of PBC, HBV and AAH patients but not HCV patients.
In this study, for the first time in diseased liver tissue, we have demonstrated that a large proportion of PBC patients have disease specific autoantibodies against liver sinusoidal cells.
研究原发性胆汁性肝硬化(PBC)患者中针对肝窦状细胞的自身抗体的存在情况。
对21例PBC患者的肝活检组织进行研究,并与12例疾病对照组的肝活检组织进行比较[3例乙型肝炎(HBV)病毒患者、3例丙型肝炎病毒(HCV)患者、3例非酒精性脂肪性肝炎患者和3例急性酒精性肝炎(AAH)患者]。作为健康对照,我们使用了转移性肝腺癌旁的组织标本。正常血清取自该科室工作人员。使用石蜡包埋的肝切片作为底物,通过间接免疫荧光(IIF)分析确定患者血清中自身抗体所靶向的细胞类型。来自同源或异源PBC患者的血清或疾病对照组的血清用作一抗。使用共聚焦显微镜鉴定自身抗体的存在情况。
当使用同源血清和异硫氰酸荧光素偶联的免疫球蛋白G(IgG)二抗时,总共21例PBC患者中有18例(85.7%)在肝窦状细胞中呈现阳性染色,10例(47.6%)在淋巴细胞中,8例(38%)在胆管细胞中,7例(33.3%)在肝细胞中。用异源PBC血清孵育的PBC切片显示染色减少(肝窦状细胞为20%,淋巴细胞为20%,胆管细胞为20%,肝细胞为13.3%)。当使用IgM免疫球蛋白而非IgG作为二抗时,在75%的淋巴细胞、62.5%的胆管细胞、37.5%的肝细胞和50%的肝窦状细胞中观察到阳性染色,且染色强度更强。当在疾病对照组的肝切片上使用正常血清或PBC血清作为一抗时,未观察到染色。当PBC血清与健康对照切片孵育时,在21例PBC血清样本中有3例(14.3%)观察到胆管细胞弱阳性染色。脂肪性肝炎血清在PBC切片上使一些肝细胞和淋巴细胞呈阳性染色,但在病毒性肝炎切片上无染色。用HBV血清孵育使PBC、HBV和AAH患者的一些肝细胞、胆管细胞以及肝窦内或门静脉淋巴细胞染色,但HCV患者未染色。
在本研究中,我们首次在患病肝组织中证明,很大一部分PBC患者具有针对肝窦状细胞的疾病特异性自身抗体。